Biocide Risk Assessment

Human health:

Depending on the product type and application the use of biocidal products must be shown to be safe by conducting an in depth risk assessment, considering both chronic and acute exposure. Enviresearch is able to evaluate critically both the hazard and exposure based on your proposed use.

Exposure to the active substance occur through its full life cycle, a range of scenarios therefore need to be considered and appropriate exposure models such as EUSES, EASE CONSEXPO and BEAT may be needed to quantify the exposures. Although Annex I only requires acceptable consumer risk to be demonstrated for representative uses, additional risk assessments will be required for product authorisation to include all uses in each Member State. Enviresearch has experience in conducting these risk assessments.

Human risk assessment requires a multidisciplinary approach, whether supporting AOELs from toxicological studies, modelling exposure scenarios, or generating higher tier data such as dermal absorption or actual field studies. Whether you are pursuing Annex I listing or applying for product authorisation, we are able to provide expert advice at all stages.